Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.WT | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by jojomarchon Dec 15, 2019 7:12pm
150 Views
Post# 30457557

RE:RE:RE:RE:RE:RE:RE:RE:Come on ----Lets have a guessing game--

RE:RE:RE:RE:RE:RE:RE:RE:Come on ----Lets have a guessing game--
Hempdoc wrote:
Macer wrote:
goldn1 wrote:
cry: I think what you are missing is that the results along the way will dictate the success of the trial. It is naive to say we should close our eyes and wait until 2020, if PH2 shows the first 5-10 or 15 patients w CR after 90 days, that bodes well for the overall trial, giving confidence for more people to enroll and for doctors, iviestors and regulators to take notice. Yes, we will want to see 360 and 540 results, but the initial results will dictate how this trial goes long term. Imo G1


In my humble opinion the 3 month data will only reconfirm the phase 1 trial results. All of the patients in phase 1 were cancer free at 3 months. I honestly believe the 6 month data will be pivital. If everyone is cancer free at 6 months and also receives a second treatment I believe this will be predictive of the 12 months results. We may even appreciate some findings that can only be explained by the immune response effect.
Either way the 6 month data is key in my mind
macer


 

 

All IMHO.....
Though a very small sample size was analyzed for Ph 1, we are batting a 1000% for non-UTUC patients who received the therapeutic dosing.  Adding more positive 90 day data from Ph 2 will certainly boost my confidence even more in the efficacy of our treatment at the therapeutic dose.  The 90 day data of "all" patients in Ph 1 simply tells me how effective our ACT is, even at sub-therapeutic doses.  So, based on Ph 1 data at the therapeutic dose, I have little cause for concern there will be any significant drop in CR from 3 to 6 months.  Having said that, if 6 month data impress, the likelihood of impressive data at 12 months will almost be guaranteed with the planned 2nd treatment, which we may discover down the road may not even be necessary...best of luck.



I too , like some posters , think the 6 months results are very important because of the repeat nature of this PH2 clinical trial . What will happen is some heavy speculation before the 6 month results IMO , so keeping this in mind the SP of TLT will go parabolic in the next few months .

Cheers

Bullboard Posts